No black box warning on record for Epoprostenol

As of the latest FDA labeling reviewed, Epoprostenol (EPOPROSTENOL) does not carry a black box warning. Standard warnings and precautions still apply — see the full Epoprostenol medicine page for the complete safety profile.

Other warnings & precautions

5 WARNINGS AND PRECAUTIONS • Do not abruptly lower the dose or withdraw dosing. All dosing initiation and changes should be closely monitored. ( 5.2 , 5.3 ) 5.1 Dose Initiation Epoprostenol is a potent pulmonary and systemic vasodilator. Initiate epoprostenol in a setting with adequate personnel and equipment for physiologic monitoring and emergency care. Dose initiation has been performed during

No black box warning on record for Epoprostenol

Other warnings & precautions

5 WARNINGS AND PRECAUTIONS • Do not abruptly lower the dose or withdraw dosing. All dosing initiation and changes should be closely monitored. ( 5.2 , 5.3 ) 5.1 Dose Initiation Epoprostenol is a potent pulmonary and systemic vasodilator. Initiate epoprostenol in a setting with adequate personnel and equipment for physiologic monitoring and emergency care. Dose initiation has been performed during

Epoprostenol Black Box Warning

No black box warning on record for Epoprostenol

Other warnings & precautions

Epoprostenol Black Box Warning

No black box warning on record for Epoprostenol

Other warnings & precautions